Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Ferenc G. Rick"'
Autor:
Martin Leustik, Maritza Romero, Helena Pillich, Norman L. Block, Ferenc G. Rick, Jonathan Lawson, Alexander Verin, Aluya Oseghale, Umapathy Siddaramappa, Boris Gorshkov, Evgeny Zemskov, Supriya Sridhar, Istvan Czikora, Rudolf Lucas, Andrew V. Schally, Trinad Chakraborty
Publikováno v:
Toxins, Vol 5, Iss 7, Pp 1244-1260 (2013)
Severe pneumonia is the main single cause of death worldwide in children under five years of age. The main etiological agent of pneumonia is the G+ bacterium Streptococcus pneumoniae, which accounts for up to 45% of all cases. Intriguingly, patients
Externí odkaz:
https://doaj.org/article/f087281299e04b3983ec7d671837bb53
Autor:
Ferenc G. Rick, Norman L. Block
Publikováno v:
EBioMedicine, Vol 7, Iss C, Pp 13-14 (2016)
Externí odkaz:
https://doaj.org/article/9a6aa567fbdd4ba292c185ed2e871661
Autor:
Ren Zhi Cai, Ronan T. Swords, Aymee Perez, Gina M. DelCanto, Petra Popovics, Ailin Vila Granda, Ferenc G. Rick, Andrew V. Schally, Joaquin J. Jimenez, Irving Vidaurre
Publikováno v:
British Journal of Haematology. 181:476-485
Growth hormone-releasing hormone (GHRH) is secreted by the hypothalamus and acts on the pituitary gland to stimulate the release of growth hormone (GH). GHRH can also be produced by human cancers, in which it functions as an autocrine/paracrine growt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7e2efe36af8e0eca2b5f682eb7591d1
https://doi.org/10.1111/bjh.15207
https://doi.org/10.1111/bjh.15207
Autor:
Renzhi Cai, Tengjiao Cui, Jozsef L. Varga, Luca Szalontay, Marta Zarandi, Gabor Halmos, Andrew V. Schally, Xian Yang Zhang, Ferenc G. Rick, Petra Popovics, Wei Sha, Magdolna Kovacs, Norman L. Block, Miklós Jászberényi
Publikováno v:
Peptides. 89:60-70
The syntheses and biological evaluations of new GHRH analogs of Miami (MIA) series with greatly increased anticancer activity are described. In the design and synthesis of these analogs, the following previous substitutions were conserved: D-Arg2, Ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12287686b91c9f194313aa0ab0a1eef3
https://doi.org/10.1016/j.peptides.2017.01.009
https://doi.org/10.1016/j.peptides.2017.01.009
Publikováno v:
Current Drug Targets. 17:488-494
Receptors for LHRH (luteinizing hormone-releasing hormone) are expressed in about 80% of human endometrial, ovarian and prostate cancers and are also found in more than 50% of breast cancers including triple negative breast cancers. In the human body
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d47bb023c3a64268b1c553f9bbd1b06
https://doi.org/10.2174/138945011705160303154717
https://doi.org/10.2174/138945011705160303154717
Autor:
Ferenc G. Rick, Rudolf Lucas, Norman L. Block, Supriya Sridhar, David Fulton, Neal L. Weintraub, Maritza J. Romero, Subbaramiah Sridhar, Andrew V. Schally, Huijuan Dou, Zsolt Bagi, Eby M. Mosieri, Istvan Czikora
Publikováno v:
Proceedings of the National Academy of Sciences. 113:1895-1900
Dyslipidemia associated with triglyceride-rich lipoproteins (TRLs) represents an important residual risk factor for cardiovascular and chronic kidney disease in patients with type 1 diabetes (T1D). Levels of growth hormone (GH) are elevated in T1D, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7016d0b86b4bf5e83305442d50d68fd1
https://doi.org/10.1073/pnas.1525520113
https://doi.org/10.1073/pnas.1525520113
Publikováno v:
Journal of Urology. 199
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42347bd292663604f5202551b6fc3b4c
https://doi.org/10.1016/j.juro.2018.02.1444
https://doi.org/10.1016/j.juro.2018.02.1444
Publikováno v:
The Prostate. 78(13)
Background Inflammation plays a key role in the etiology of benign prostatic hyperplasia (BPH) through multiple pathways involving the stimulation of proliferation by cytokines and growth factors as well as the induction of the focal occurrence of ep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a021c0df1303279f7b0ae3973c2355a3
https://pubmed.ncbi.nlm.nih.gov/29786867
https://pubmed.ncbi.nlm.nih.gov/29786867
Autor:
Joshua M. Hare, Norman L. Block, Marta Zarandi, Luca Szalontay, Ren Zhi Cai, Miklós Jászberényi, Petra Popovics, Rosemeire M. Kanashiro-Takeuchi, Andrew V. Schally, Ferenc G. Rick, Lauro M Takeuchi, Irving Vidaurre
Publikováno v:
Oncotarget
// Rosemeire M. Kanashiro-Takeuchi 1, 2, * , Luca Szalontay 3, * , Andrew V. Schally 1, 3, 4, 5, 6 , Lauro M. Takeuchi 1 , Petra Popovics 3, 7, 8 , Miklos Jaszberenyi 3, 4 , Irving Vidaurre 3 , Marta Zarandi 3 , Ren-Zhi Cai 3, 4 , Norman L. Block 1,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbb355def90d25a7baef45106b1f2c19
https://doi.org/10.18632/oncotarget.3303
https://doi.org/10.18632/oncotarget.3303
Publikováno v:
Expert Opinion on Therapeutic Targets. 19:617-632
Increasing evidence suggests that prostate cancer cells undergo unique metabolic reprogramming during transformation. A master regulator of cellular homeostasis, 5'-AMP-activated protein kinase (AMPK), directs metabolic adaptation that supports the g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afb91c269c0618b9ac38d5e3e19900a3
https://doi.org/10.1517/14728222.2015.1005603
https://doi.org/10.1517/14728222.2015.1005603